Effects of short-acting NMDA receptor antagonist MRZ 2/576 on morphine tolerance development in mice

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 361, Issue 6, 2000, Pages 573-577

  Belozertseva, Irina V ^a   Danysz, Wojciech ^b   Bespalov, Anton Y ^a  

^a PAVLOV FIRST SAINT PETERSBURG STATE MEDICAL UNIVERSITY   (Russian Federation)

^b MERZ PHARMACEUTICALS GMBH   (Germany)

Author keywords

Analgesia; Mice; Morphine; MRZ 2 576; NMDA receptor antagonist; Tolerance

Indexed keywords

MORPHINE; MRZ 2576; N METHYL DEXTRO ASPARTIC ACID;

ANALGESIA; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG RECEPTOR BINDING; MALE; MORPHINE TOLERANCE; MOUSE; NONHUMAN;

ANALGESIA; ANALGESICS, OPIOID; ANIMALS; BEHAVIOR, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG TOLERANCE; HALF-LIFE; MALE; MICE; MORPHINE; PAIN MEASUREMENT; PHTHALAZINES; RECEPTORS, N-METHYL-D-ASPARTATE; TIME FACTORS;

EID: 0004607726     PISSN: 00281298     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002109900207     Document Type: Article

References (25)

1. Belozertseva IV, Bespalov AY (1998) Effects of NMDA receptor channel blockers, dizocilpine and memantine, on the development of opiate analgesic tolerance induced by repeated morphine exposures or social defeats in mice. Naunyn-Schmiedeberg's Arch Pharmacol 358:270-274
2. Ben-Eliyahu S, Marek P, Vaccarino AL, Mogil JS, Sternberg WF, Liebeskind JC (1992) The NMDA receptor antagonist MK-801 prevents long-lasting non-associative morphine tolerance in the rat. Brain Res 575:304-308
3. Bespalov AY, Belozertseva IV, Danysz W (1998a) Application of short-acting NMDA receptor antagonist acting at the glycine site MRZ 2/576 to study morphine tolerance and dependence in mice. Abstr Soc Neurosci 24:577
4. Bespalov AY, Kudryashova MF, Zvartau EE (1998b) Prolongation of morphine analgesia by competitive NMDA receptor antagonist D-CPPene in rats. Eur J Pharmacol 351:299-305
5. Chen L, Huang L-YM (1991) Sustained potentiation of NMDA receptor-mediated glutamate responses through activation of protein kinase C by a μ-opioid. Neuron 7:319-326
6. Danysz W, Parsons CG (1998) Glycine and NMDA receptors - physiological significance and possible therapeutic applications. Pharmacol Rev 50:597-664
7. Gerber G, Kangrga I, Ryu PD, Larew JS, Randic M (1989) Multiple effects of phorbol esters in the rat spinal dorsal horn. J Neurosci 9:3606-3617
8. Grass S, Hoffmann O, Xu XJ, Wiesenfeld-Hallin Z (1996) N-methyl-D-aspartate receptor antagonists potentiate morphine's antinociceptive effect in the rat. Acta Physiol Scand 158:269-273
9. Herman BH, Vocci F, Bridge P (1995) The effects of NMDA receptor antagonists and nitric oxide synthase inhibitors on opioid tolerance and withdrawal - medication development issues for opiate addiction. Neuropsychopharmacology 13:269-293
10. B-site: microdialysis and MES studies. J Pharmacol Exp Ther 290:543-550
11. Hucker HB, Hutt JE, White SD, Arison BH, Zacchei AG (1983) Disposition and metabolism of (+)-5-methyl-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5,10-imine in rats, dogs and monkeys. Drug Metab Dispos 11:54-58
12. Kesner RP, Priano DJ (1977) Disruptive effects of naloxone on development of morphine tolerance. Life Sci 21:509-512
13. Kissin I, Brown PT, Robinson CA, Bradley EL Jr (1991) Acute tolerance in morphine analgesia: continuous infusion and single injection in rats. Anesthesiology 74:166-171
14. Kolesnikov YA, Maccechini ML, Pasternak GW (1994) 1-Amino-cyclopropane carboxylic acid (ACPC) prevents mu and delta opioid tolerance. Life Sci 55:1393-1398
15. Larcher A, Laulin JP, Celerier E, Le Moal M, Simonnet G (1998) Acute tolerance associated with a single opiate administration: involvement of N-methyl-D-aspartate-dependent pain facilitatory systems. Neuroscience 84:583-589
16. Laulin JP, Larcher A, Celerier E, Le Moal M, Simonnet G (1998) Long-lasting increased pain sensitivity in rat following exposure to heroin for the first time. Eur J Neurosci 10:782-785
17. Laulin JP, Celerier E, Larcher A, Le Moal M, Simonnet G (1999) Opiate tolerance to daily heroin administration: an apparent phenomenon associated with enhanced pain sensitivity. Neuroscience 89:631-636
18. Lutfy K, Shen KZ, Kwon IS, Cai SX, Woodward RM, Keana JF, Weber E (1995) Blockade of morphine tolerance by ACEA-1328, a novel NMDA receptor/glycine site antagonist. Eur J Pharmacol 273:187-189
19. Lutfy K, Shen KZ, Woodward RM, Weber E (1996) Inhibition of morphine tolerance by NMDA receptor antagonists in the formalin test. Brain Res 731:171-181
20. Marek P, Ben-Eliyahu S, Gold M, Liebeskind JC (1991a) Excitatory amino acid antagonists (kynurenic acid and MK-801) attenuate the development of morphine tolerance in the rat. Brain Res 547:77-81
21. Marek P, Ben-Eliyahu S, Vaccarino AL, Liebeskind JC (1991b) Delayed application of MK-801 attenuates development of morphine tolerance in rats. Brain Res 558:163-165
22. Parsons CG, Danysz W, Quack G, Hartmann S, Lorenz B, Wollenburg C, Baran L, Przegalinski E, Kostowski W, Krzascik P, Chizh B, Headley PM (1997) Novel systemically-active antagonists of the glycine site of the NMDA receptor - electrophysiological, biochemical and behavioral characterization. J Pharmacol Exp Ther 283:1264-1275
23. Siegel S (1988) Drug anticipation and drug tolerance. In: Lader M (ed) The psychopharmacology of addiction. Oxford University Press, London, pp 73-96
24. Trujillo KA, Akil H (1991) Inhibition of morphine tolerance and dependence by the NMDA receptor antagonist MK-801. Science 251:85-87
25. Urca G, Raigorodsky G (1988) Behavioral classification of excitatory amino acids receptors in mouse spinal cord. Eur J Pharmacol 153:211-220